Thursday, 30 Oct 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    Intento Releases 9th Annual “State of Translation Automation 2025” Industry Report
    Intento Releases 9th Annual “State of Translation Automation 2025” Industry Report
    30/10/2025
    SBI Life’s ‘Thanks-A-Dot’ sets a GUINNESS WORLD RECORDS, making breast health a living room conversation across communities
    30/10/2025
    e& continues strong growth in Q3 2025 with consolidated revenues up 29.2% to AED 18.6 billion
    e& continues strong growth in Q3 2025 with consolidated revenues up 29.2% to AED 18.6 billion
    29/10/2025
    NABR: New review of long-tailed macaque population recommends two steps for accurate reassessment of long-tailed macaque global population
    NABR: New review of long-tailed macaque population recommends two steps for accurate reassessment of long-tailed macaque global population
    29/10/2025
    Hexaware Comments on Meritless Patent Lawsuit Filed by Natsoft
    Hexaware Comments on Meritless Patent Lawsuit Filed by Natsoft
    28/10/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • global
  • Business
  •  and
  • announced
  • today
  •  the
  • june
  • company
  • Tech
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Health

Algernon Announces Preferred Share Class Approved at Annual and Special Meeting

GlobeNews Wire
Last updated: 20/09/2025 2:31 AM
GlobeNews Wire
Share
6 Min Read
Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
SHARE
Algernon Announces Preferred Share Class Approved at Annual and Special Meeting

VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces the voting results at its annual and special meeting of shareholders held earlier today (the “Meeting”) including an ordinary resolution (the “Resolution”) to approve an alteration to the Company’s authorized share structure and Articles, to include an unlimited number of Preferred Shares, of which an unlimited number of Preferred Shares will be designated as Series 1. The Resolution received greater than 93% of the votes in favor.

The Series 1 Preferred Shares include a ten percent annual dividend payable in Common Shares or Preferred Shares at the discretion of the Company’s Board of Directors and are convertible into, without payment of any consideration and without further action on the part of the holder thereof, ten Common Shares. Following the approval of the Resolution, the Company will issue 450,000 Preferred Shares and 450,000 Preferred Warrants pertaining to an acquisition completed on May 22, 2025 and 1,268,334 Preferred Shares and 634,167 Preferred Warrants pertaining to a private placement of subscription receipts closed on July 24, 2025.

Additionally, the Company announces the voting results for the election of its directors. Each of the five nominees listed in Company’s management information circular dated July 31, 2025, namely Harry J.F. Bloomfield KC, Christopher J. Moreau, Dr. Raj Attariwala, Dr. Mark Williams and U.S. Ambassador (Rtd) Howard Gutman was elected as directors of Algernon to hold office until the next annual meeting of shareholders or until their successor is duly elected. Each director received votes for, totaling greater than 95%.

The Company recently announced its plans to change its name to Algernon Health Inc. from Algernon Pharmaceuticals Inc., to better reflect its added work in the Alzheimer’s Disease diagnostic market and its plans to establish specialized neuroimaging clinics across North America as its lead program.

Christopher J. Moreau
CEO
Algernon Pharmaceuticals, Inc.
604.398.4175 ext 701
info@algernonpharmaceuticals.com
investors@algernonpharmaceuticals.com
www.algernonpharmaceuticals.com.

About Algernon Pharmaceuticals

Algernon Pharmaceuticals is a Canadian healthcare company focused on the provision of brain specific PET scanning services through a planned network of new clinics in North America for the detection of Alzheimer’s disease, as well as other forms of dementia, epilepsy, neuro-oncology, and movement disorders. Algernon is also the parent company of a private subsidiary called Algernon NeuroScience that has been advancing a psychedelic program investigating a proprietary form of DMT for stroke and traumatic brain injury. The Company also owns a 20% equity position in Seyltx, a private U.S. based drug development company advancing a chronic cough drug called Ifenprodil.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY DISCLAIMER STATEMENT: No Securities Exchange has reviewed nor accepts responsibility for the adequacy or accuracy of the content of this news release. This news release contains forward-looking statements relating to product development, licensing, commercialization and regulatory compliance issues and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include the failure to satisfy the conditions of the relevant securities exchange(s) and other risks detailed from time to time in the filings made by the Company with securities regulations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.

UPI Launches Program to Extend Payment Network for International Students
ESR and Colt DCS Announce Joint Venture on New Osaka Data Centre Development
Xinhua Silk Road: First Xingsha-Africa Coffee Carnival launched in Changsha County, C. China’s Hunan Province
Parimatch Created Cricket Festival Boxes for Fans to Enjoy the Indian T20 League to the Fullest
Kia showcases its extensive EV portfolio at IAA Mobility 2025
TAGGED: andalgernonannouncesannualapprovedbritishCA01559R1038classCNSX:AGNCNSX:AGN.CNcommoncompanycompanysdirectorselectedFrankfurt:AGW0.FgreaterincludejulymeetingnewsnumberOther OTC:AGNPFpertainingpreferredreceivedresolutionresultsseriesshareshareholderssharesspecialtenunlimitedvancouvervotesvotingwarrantswillwithout
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

APsystems Named Most Bankable Inverter Company Worldwide by Sinovoltaics
Entertainment

APsystems Named Most Bankable Inverter Company Worldwide by Sinovoltaics

01/09/2025
Guidelines for Osstem Implants, Implant Fracture and Peripheral Diseases are Presented
Entertainment

Guidelines for Osstem Implants, Implant Fracture and Peripheral Diseases are Presented

06/08/2025
CGTN: Bridging dialogue: China promotes integration, mutual learning among civilizations
News

CGTN: Bridging dialogue: China promotes integration, mutual learning among civilizations

13/07/2025
Craft Silicon and MindHYVE.ai Forge Strategic Partnership to Deploy Agentic AI Across Africa’s Workforce and Education Systems
Business

Craft Silicon and MindHYVE.ai Forge Strategic Partnership to Deploy Agentic AI Across Africa’s Workforce and Education Systems

12/09/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?